RxDoctor Payments Data

Bolling Haygood

Baton Rouge, LANPI 1396731915

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 159 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 17.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,800 and has fallen 99.3% since, to $12 in 2021.

$2,635in general payments, 2019–2025

Across 159 payments — averaging $16.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$454
  • GSK$373
  • UCB, Inc.$241
  • Johnson & Johnson$194
  • Mallinckrodt Enterprises LLC$181
  • Portola Pharmaceuticals, LLC$179
  • plus $1K from 19 others

What the payments were for

  • Food & beverage$2,635100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Where these figures come from

Is this you, or does something look wrong? →